Patents by Inventor Zhenhui Xu

Zhenhui Xu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10378849
    Abstract: A testing device for study of a magnetized plasma artillery and gunpowder, comprising a pedestal, wherein a top end of the pedestal is provided with a sliding slot for mounting a buffer device, which penetrates through an upper part of the pedestal along a front-rear direction. The sliding slot for mounting the buffer device is internally provided with a buffering slider, which can slide back and forth along the sliding slot for mounting the buffer device. A top end of the buffering slider is provided with a gunpowder combustion chamber fixing groove, which penetrates through an upper part of the buffering slider along the front-rear direction. The gunpowder combustion chamber fixing groove is internally provided with a gunpowder combustion chamber, and an upper part of the gunpowder combustion chamber is provided with a positioning ferrule for fixing the gunpowder combustion chamber.
    Type: Grant
    Filed: November 12, 2018
    Date of Patent: August 13, 2019
    Assignee: PEOPLE'S LIBERATION ARMY ARMY ACADEMY OF ARMORED FORCES
    Inventors: Baoquan Mao, Xianghua Bai, Yuying Yang, Hua Li, Zhenhui Xu, Cheng Li, Shuai Feng, Rui Zhu, Zhiqian Wang, Tianyi Zhang
  • Publication number: 20120148621
    Abstract: The present invention is directed to a method for promoting or stimulating a cell-mediated immune response to an antigen, by administering a target antigen (such as a protein) with a transport factor that contains a fragment of a bipartite protein exotoxin, but not the corresponding protective antigen. Preferred transport factors include the protective antigen binding domain of lethal factor (LFn) from B. anthracis, consisting of amino acids 1-255, preferably a fragment of at least 80 amino acids that shows at least 80% homology to LFn, and a fragment of about 105 amino acids from the carboxy portion that does not bind PA. The target antigen can include any molecule for which it would be desirable to elicit a CMI response, including viral antigens and tumor antigens.
    Type: Application
    Filed: June 11, 2010
    Publication date: June 14, 2012
    Applicant: VACCINE TECHNOLOGIES, INCORPORATED
    Inventors: Yichen Lu, Nicholas Kuchner, Amie Strong, Zhenhui Xu